The results showed significant interactions between the stage of periodontitis and treatment effects for PD, CAL, MDA, TAC, and SOD (p < 0.05), with greater improvements observed in the test group compared with the control group in stages III and IV. The gene discussed is SOD1; the disease is periodontitis.